Matricelf Ltd (MTLF) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Matricelf Ltd (MTLF) has a cash flow conversion efficiency ratio of -997.589x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (ILA-8.28 Million ≈ $-22.18K USD) by net assets (ILA8.29K ≈ $22.24 USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See MTLF net asset quality index to measure how much of total assets are equity-financed.
Matricelf Ltd - Cash Flow Conversion Efficiency Trend (2019–2024)
This chart illustrates how Matricelf Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore MTLF cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Matricelf Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Matricelf Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Amanet Management & Systems Ltd
TA:AMAN
|
0.066x |
|
Pergamon Status Dis Ticaret AS
IS:PSDTC
|
-0.002x |
|
Caspin Resources Ltd
AU:CPN
|
-0.288x |
|
Retractable Technologies Inc
NYSE MKT:RVP
|
-0.008x |
|
Higher Way Electronic Co Ltd
TWO:3268
|
-0.040x |
|
Nanollose Ltd
AU:NC6
|
6.134x |
|
Kingston Resources Ltd
AU:KSN
|
0.081x |
|
Holista Colltech Ltd
AU:HCT
|
-0.382x |
Annual Cash Flow Conversion Efficiency for Matricelf Ltd (2019–2024)
The table below shows the annual cash flow conversion efficiency of Matricelf Ltd from 2019 to 2024. For the full company profile with market capitalisation and key ratios, see Matricelf Ltd stock valuation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | ILA15.17 Million ≈ $40.66K |
ILA-11.75K ≈ $-31.51 |
-0.001x | -98.09% |
| 2023-12-31 | ILA26.80 Million ≈ $71.86K |
ILA-10.49K ≈ $-28.12 |
0.000x | +99.83% |
| 2022-12-31 | ILA35.79 Million ≈ $95.96K |
ILA-8.30 Million ≈ $-22.25K |
-0.232x | +8.20% |
| 2021-12-31 | ILA26.23 Million ≈ $70.32K |
ILA-6.62 Million ≈ $-17.76K |
-0.253x | +79.57% |
| 2020-12-31 | ILA2.80 Million ≈ $7.50K |
ILA-3.46 Million ≈ $-9.27K |
-1.236x | -1354.61% |
| 2019-12-31 | ILA3.62 Million ≈ $9.71K |
ILA-307.80K ≈ $-825.19 |
-0.085x | -- |
About Matricelf Ltd
Matricelf Ltd, a biotechnology company, develops a platform for autologous tissue engineering for various medical conditions. The company's regenerative medicine platform intends to cure a range of medical conditions, including spinal cord injuries, age-related macular degeneration, Parkinson's disease, and myocardial infarction, as well as for 3D bioprinting. Matricelf Ltd was incorporated in 20… Read more